Attended a Live Program?
Print Certificate
Low muscle mass is prevalent among patients with cancer and is a predictor of adverse clinical outcomes. To counteract muscle loss, supplements containing βeta-hydroxy βeta-methylbutyrate, or HMB, have been proposed as a potential therapy. HMB is a metabolite of leucine that positively impacts muscle mass through promoting muscle protein synthesis and reducing muscle protein breakdown. This video summarizes a systematic review that investigated the effects and safety of HMB supplementation on outcomes in patients with cancer.
Dans cette vidéo, Michael Bastasch, MD, Martin Chasen, MBChB, FCP, Maureen Gardner, MSc, DtP, CSO, LD/N, FAND, Alessandro Laviano, MD, Carla Prado, PhD, DtP, et Anthony Sung, MD, nous parlent d’interventions multimodales, portant sur l’alimentation et l’exercice, et de la façon dont celles-ci peuvent améliorer les résultats obtenus chez les patients atteints d’un cancer.
In this video, Michael Bastasch, MD, Suzanne Dixon, MPH, MS, RDN, Alessandro Laviano, MD, and Şuayib Yalçın, MD, review the role of malnutrition screening for all patients with cancer, regardless of body mass index (BMI), as well as the role of the electronic health record (EHR) and multidisciplinary team to make screening successful.
In this video, Michael Bastasch, MD, Martin Chasen, MBChB, FCP, Suzanne Dixon, MPH, MS, RDN, Maureen Gardner, MA, RDN, CSO, LD/N, FAND, Alessandro Laviano, MD, Carla Prado, PhD, RD, and Shila Newman, RN, OCN, ONN-CG, discuss the team approach to nutrition care, including the roles of the registered dietitian nutritionist (RDN) and nurse navigator, as well as the role of the patient and caregiver.
In this 1:56-minute video, Domina Kekez, MD, Richard JE Skipworth, MBChB, MD, and Karin Jordan, MD, PhD, discuss how integrating nutritional care into their practice can significantly contribute to better health outcomes for their patients.
In this 3:25-minute video, you'll learn about the benefits of good nutrition during cancer treatment.
In this video, Michael Bastasch, MD, Martin Chasen, MBChB, FCP, Maureen Gardner, MA, RDN, CSO, LD/N, FAND, Alessandro Laviano, MD, Carla Prado, PhD, RD, and Anthony Sung, MD, discuss multimodal intervention, including nutrition and exercise, and how it can improve outcomes in patients with cancer.
Dans cette vidéo, Michael Bastasch, MD, Martin Chasen, MBChB, FCP, Maureen Gardner, MSc, DtP, CSO, LD/N, FAND, Alessandro Laviano, MD, Carla Prado, PhD, DtP, et Anthony Sung, MD, nous parlent d’interventions multimodales, portant sur l’alimentation et l’exercice, et de la façon dont celles-ci peuvent améliorer les résultats obtenus chez les patients atteints d’un cancer.
Abbott Nutrition Health Institute (ANHI) held a scientific roundtable on “Evidence and Opportunities: Oncology Nutrition in 2020” on 14-15 October 2020. The event included 10 clinical experts from around the globe for a scientific discussion on new evidence, consensus, and guidelines for optimal nutrition care for patients with cancer.
Early identification of patients with cancer commencing or undergoing antineoplastic therapy who are at nutritional risk is critical for optimizing treatment success. PRONTO (Protocol for Nutritional Risk in Oncology) provides a standardized approach for healthcare professionals treating patients with cancer to quickly identify those with or at risk of malnutrition and/or low strength or mobility for further evaluation and follow-up with members of the multidisciplinary care team.
In this short video, Domina Kekez, MD, Marieke Schooneman, MD, PhD, and Karin Jordan, MD, emphasize the critical importance of implementing proper nutrition in cancer care, highlighting how it helps patients sustain their strength, energy, and overall well-being throughout treatment.
In this short video, Domina Kekez, MD, Marieke Schooneman, MD, PhD, and Karin Jordan, MD, describe how essential nutrients and good nutrition play a crucial role in the effectiveness of cancer treatment and the patient's quality of life.
For patients who are newly diagnosed with cancer, it’s sometimes hard to understand a diagnosis and what’s ahead. We’ve created four new infographics you can download, print, and share with your patients to help them stay informed and feel supported during their cancer journey.
In November 2020, ANHI hosted a roundtable of experts to discuss oncology and nutrition. The discussion was so insightful, we reconvened in January 2021 to interview several of the roundtable experts for this podcast series.
In this 17-minute episode, Chelsia Gillis, PhD, RD, discusses surgical prehabilitation in oncology patients; reviews what's new in terms of concepts for evidence for prehabilitation, especially for frail patients; and explains risk-stratified and targeted prehabilitation care.
In this course, the faculty will review the impact of malnutrition and muscle loss on clinical outcomes in patients with cancer; summarize body composition techniques for muscle mass assessment and implications for clinical practice; and identify new clinical data on protein and hydroxymethylbutyrate (HMB) as interventions for patients with cancer. Originally presented on 05 September 2022, at the ESPEN Congress in Vienna, Austria.
In this course, the faculty will describe the significance of skeletal muscle as a metabolic organ and early screening in adult patients; review the role of muscle health in patients with type 2 diabetes; and summarize recent findings on the importance of muscle and nutrition in the oncology setting. Originally presented live at the 45th ESPEN Congress in Lyon, France.
In this course, Dr Julie Whitney will clarify the principles of exercise to strengthen muscle, including how to optimise uptake and adherence; discuss the difference between exercise, and physical activity; and review the evidence-based muscle strengthening exercise for COPD, oncology, falls, and frailty. Originally presented live on 14 June 2023.
In this course, you’ll identify the multifactorial aetiology of frailty, including malnutrition and sarcopenia as major risk factors; describe the factors that contribute to malnutrition in oncology and the impact of muscle loss in treatment and recovery; explain the importance of functional parameters and introduce practical tools for screening and diagnosing muscle loss; and describe interventions to support and improve muscle health in clinical practice. Originally presented live on 22 November 2022.
In this course, Julia McAdam, RGN, PGDip, MA, will discuss the impact of malnutrition and loss of muscle for oncology patients; identify practical ways to assess malnutrition and muscle mass and function; introduce the importance of nutrition as a key part of prehabilitation; and explain the nutritional needs of malnourished oncology patients. Originally presented as a live webinar on 23 March 2022.
There is limited research on malnutrition quality improvement programs (QIPs) in cancer care. This article outlines gaps and potential opportunities for QIPs in the nutrition support of patients with cancer.
People with cancer can face challenges related to their diagnosis or treatment which impact their physical, nutritional and psychological health. This article shows an example of how trimodal prehabilitation is successful in achieving better patient outcomes.
This article, published in the open-access journal Nutrients, evaluated current trends in the literature and reported evidence around the timing and impact of specific nutrition interventions in oncology patients undergoing active cancer treatment. The identified studies examined the impacts of nutrition interventions (nutrition counseling, oral nutrition supplements, or combination of both) on a variety of cancer diagnoses.
Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognized and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes.
In order to provide a high-quality nutritional care, care pathways are recommended. Standardisation and clear documentation in care pathways provide a mechanism for delivering efficient and effective care, and should include aspects of screening, assessment & diagnosis, intervention, and monitoring & evaluation. Nutritional intervention in cancer patients should aim to identify and treat malnutrition, maintain or improve muscle mass and address nutritional disturbances. Some nutrients have been highlighted to be of special importance to achieve this, such as protein, vitamin D and beta-hydroxy-beta-methylbutyrate. This article shows the process of how to implement a nutritional care pathway for cancer patients.
The Oncology Care Model (OCM) is a US Centers for Medicare & Medicaid Services (CMS) specialty model implemented to provide higher quality, more highly coordinated oncology care at the same or lower costs. Nutrition is a component of best-practice cancer care, yet it may not be addressed by OCM providers even though up to 80% of patients with cancer develop malnutrition and poor nutrition has a profound impact on cancer treatment and survivorship. This paper outlines how and why quality nutrition care is integral to the OCM and can benefit patient health and provider outcomes.
This article published August 8, 2020, in the open-access Journal of Clinical Nutrition and Food Science, describes the issue of malnutrition in cancer, outlines how nutrition-focused quality improvement programs (QIPs) can be developed and provides examples of two QIPs that include a cancer patient population, and finally identifies how nutrition-focused QIPs can align to support current and evolving US value-based payment programs.
You and your colleagues can stay connected to ANHI and events by subscribing to our monthly newsletter and other electronic communications.
Stay connected